Formulation

Nov 13, 2015
BioPharm International
By BioPharm International Editors
A new consortium involving Arecor, Fujifilm Diosynth Biotechnologies, and the UK's Center for Process Innovation will focus on formulation innovation as a way to improve downstream processing and reduce biopharmaceutical cost.
Oct 14, 2015
By BioPharm International Editors
The company presented a portfolio of new products during the meeting in Madrid.
Sep 29, 2015
By BioPharm International Editors
The project seeks to index the properties of various proteins in solution and create a home for data on the performance of product excipients with their active substances.
Aug 01, 2015
BioPharm International
The authors explore the use of statistical experimental design and multivariate analysis to develop a drug substance formulation matrix.
Jul 28, 2015
Will AbbVie stave off biosimilar competitors by following Teva’s model for Copaxone?
Jul 07, 2015
By BioPharm International Editors
Catalent’s licensing of Excelimmune’s antibody combination therapy platform can enable more consistent, cost effective production of antibody combinations.
Jul 01, 2015
By BioPharm International Editors
The new facility expands the company’s commercial manufacturing capability at its Bend, Ore. site.
Jul 01, 2015
BioPharm International
When using media supplements in biologics, it is important to have a key understanding of both the supplement and the base medium to ensure high titer and stability.
Jun 15, 2015
BioPharm International
By BioPharm International Editors
Contract service providers share insights on biopharma market developments and the implications of biosimilar drug approvals.
native1_300x100
lorem ipsum